Lead Plaintiff Deadline: October 04, 2021
See If You Qualify For Monetary Reward
Please Upload related files below
Fill in below.
Looking for more?
common stock pursuant and/or traceable to the documents issued in connection with the Company’s April 2021 initial public offering
(1) during the qualification process for the Company’s optical film product, Hyaline, key customers had encountered technical issues, including product shrinkage and incompatibility with customers’ processes; (2) though the qualification process was critical to achieving market acceptance for Hyaline and generating revenue, Zymergen lacked visibility into the qualification process; (3) as a result, the Company overestimated demand for its products; (4) as a result of the foregoing, the Company’s product delivery timeline was reasonably likely to be delayed, which in turn would delay revenue generation; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
In order to be included in the lawsuit, you must have incurred a loss on shares of Zymergen purchased or acquired during the class period listed above.
If you suffered a loss in Zymergen during the relevant time frame, you have until October 04, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.